Skip to main content
FinSpry Logo
FinSpry
CTOR logo
CTOR
(NASDAQ)
Citius Oncology, Inc.
$0.70-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Citius Oncology (CTOR) Stock Price & Financial Analysis

Citius Oncology Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$0.65 - $0.83
52-Week High$6.19
52-Week Low$0.49
Open$0.65
Volume433.50K
Average Volume (3M)433.50K
Market Cap61.49M
Shares Outstanding87.46M
Price to Sales (P/S)14.37
Price to Book (P/B)0.97
EV/EBITDA-2.45
Revenue (TTM)3.94M
Net Income (TTM)-23.64M
Free Cash Flow (TTM)-17.25M
EPS (TTM)$-0.27
Profit Margin-599.28%
Operating Margin-552.89%
Return on Equity (ROE)-40.46%
Debt to Equity0.07
50-Day MA$0.97
200-Day MA$1.60
52-Week Change-24.64%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Citius Oncology

What is the current stock price for CTOR?

As of the latest trading session, CTOR stock trades at $0.70. The 52-week range is $0.49–$6.19, with a day range of $0.65–$0.83.

What is the P/E ratio for CTOR?

The P/E ratio (Price-to-Earnings) for CTOR is shown in the Key Statistics section. This valuation metric helps compare Citius Oncology, Inc. to industry peers.

Does CTOR pay dividends?

Citius Oncology does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for CTOR?

Analyst ratings and recommendations for CTOR are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.

What is the market cap of CTOR?

Citius Oncology's market capitalization is $61.5M, classifying it as a micro-cap company. Citius Oncology operates in the Healthcare sector within the Drug Manufacturers - Specialty & Generic industry.